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Abstract: This review (4 tables, 88 references) describes current developments in the design
and application of liquid chromatography electrochemical detection (LC ED) based approaches
for the determination of drugs of abuse. Specific emphasis is placed on operating details and
performance characteristics for selected applications. LC ED has been shown to be highly sensitive
and specific as well being a more economic option. A wide range of abused substances have been
determined using this approach, including: cannabinoids, ethanol, opiates, morphine, mushroom
toxins, benzodiazepines and several legal highs. Reverse-phase liquid chromatography with either
amperometric or coulometric determination has been the most commonly reported applications.
However, coulometric arrays have been also reported. Detection limits in the ng/mL region have
been reported for most target analytes.
Keywords: cannabinoids; ethanol; opiates; morphine; mushroom toxins; benzodiazepines;
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1. Introduction
Drugs of abuse can be defined as drugs that are taken for nonmedicinal reasons (usually for
mind-altering effects); which can lead to physical and mental damage and with some substances,
dependence and addiction. The abuse of drugs is a significant public health problem affecting
almost every community and family playing a role in a wide range of social problems, such as
driving violations, violence, stress, child abuse and other crimes. The misuse of drugs can also
result in homelessness, and employment problems. Nevertheless, controversially, a number of these
same compounds have been the subject of recent studies [1–4] that have shown their potential
therapeutic properties. As a result there is a pressing need for analytical techniques capable of
determining these drugs and their metabolites in different sample matrices. The application of liquid
chromatography with mass spectrometry [5–8] and gas chromatography [6,8] have been widely
used and have been reviewed recently. The application of electrochemistry for the determination of
morphine has been reviewed by Tagliaro et al. [9]; however, this present review represents the first on
the liquid chromatographic electrochemical detection (LC ED) for the determination of drug of abuse.
2. Principles of Operation and Practical Considerations
More extensive and in-depth treatment of the fundamentals of LC ED can be found in a number of
reviews and monographs [10–15]. A simple explanation of liquid chromatography with electrochemical
detection would show that target analytes are separated chromatographically via their interactions
with the stationary phase (column) and mobile phase. After separation, the compounds present within
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the mobile phase enter the electrochemical detector. A number of different electrochemical detector
systems have been utilised; including conductivity, potentiometric, amperometry and coulometry. With
amperometric or coulometric based detectors compounds are either oxidized or reduced, leading to
the consumption (reduction) or liberation (oxidation) of electrons at the electrode interface. The current
formed from this is linearly related to the concentration of the analyte and hence can be used for
quantification. Two different modes of electrochemical detection are generally employed, either
amperometry or coulometry. These differ in a number of ways, but essentially on the geometry of
the working electrode and the way, and how much of the analyte interacts with the electrode: in
amperometric detection analytes flow over the working electrode surface and in coulometric electrodes,
analytes flow between surfaces of the working electrode leading to greater conversion efficiencies.
2.1. Thin Layer Cell Amperometric Detector
A number of different amperometric detectors have been described, but most commonly described
are the wall jet and the thin layer cell. The thin layer cell (Figure 1A) is based on the design originally
described by Kissinger et al. [16]. The design allows for a smooth flow of eluent over the electrode
surface; limiting baseline noise facilitating better detection limits. The small cell size also allows for
low dead volumes aiding in the overall chromatographic performance.
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Figure 1. Amperometric detector schematics: (A) channel; (B) wall-jet; (a) entrance; (b) exit;  
(c) working electrode; (d) spacer gasket; after Weber and Purdy [10]. 
2.2. Wall-Jet Amperometric Detector 
Figure 1B shows the configuration of this amperometric detector. The wall-jet configuration 
employs a nozzle or jet through which solution flows. The stream or jet of this solution impinges 
perpendicularly onto the working electrode. Fleet and Little [17] reported on the advantages of the 
geometry. The cell design is reported less susceptible to fowling; presumably due to the cleansing 
action of the solution jet. More importantly, the design is purposed to also increase the amount of the 
Figure 1. Amperometric detector schematics: (A) channel; (B) wall-jet; (a) entrance; (b) exit; (c) working
electrode; (d) spacer gasket; after Weber and Purdy [10].
2.2. Wall-Jet Amperometric Detector
Figure 1B shows th confi uration of this amperomet ic detector. The wall-jet configuration
employs a nozzle or jet t rough which solution flows. The str am or jet of this solution impinges
perpendicularly onto the working electrode. Fleet and Little [17] reported on the advantages of the
geometry. The cell design is reported less susceptible to fowling; presumably due to the cleansing
action of the solution jet. More importantly, the design is purposed to also increase the amount of the
analyte arriving at the working electrode surface. However, as the flow of the jet onto the electrode
surface can cause some degree of turbulence possible increases in baseline noise can result.
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2.3. Multi-Electrode Amperometric Detectors
It is possible to use more than one working electrode which can be arranged in a number of
configurations; such as in series, parallel or opposing (Figure 2). Recently, the application of these
multiple electrode detection has been reviewed by Honeychurch [18]. Using such approaches it
is possible to obtain not just quantitative analytical data on concentration but also electrochemical
confirmation of the eluting compound. Chao et al. [19] have described the application of parallel
mode amperometric detection (Figure 2a). In this mode, two working electrodes are held at different
potentials points along the hydrodynamic wave of the target analyte. The ratio of these currents
can then be measured and used to confirm the identity and peak purity of the eluting compound.
Further to this, it is possible to use the parallel detector in a different mode, to measure both oxidisable
and reducible species simultaneously, by applying different potential to each electrode. Co-eluting
compounds with different redox potentials can be determined by selecting the potential of one electrode
so that only the more easily oxidised (or reduced) compound is detected, while at the other parallel
electrode both compounds are electrochemically detected. The concentration of the second compound
can hence be calculated by difference.
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Figure 2. Parallel and series configurations for amperometric dual electrode detection systems.  
W1 = working electrode 1; W2 = working electrode 2. (a) Parallel; (b) Series and (c) Parallel adjacent. 
Arrow indicates direction of flow. 
Figure 2b shows the configuration of the amperometric series mode. This configuration uses the 
two working electrodes in the flow channel independently potentiostatically controlled. This can be 
compared to fluorescence detection with the product of the upstream electrode being detected at the 
downstream working electrode. When using amperometric cells such as the thin-layer cell (TLC) in 
the series mode only a small percentage of the compounds passing through the downstream 
Figure 2. Parallel and series configurations for amperometric dual electrode detection systems.
W1 = working electrode 1; W2 = working electrode 2. (a) Parallel; (b) Series and (c) Parallel adjacent.
Arrow indicates direction of flow.
Figure 2b shows the configuration of the amperometric series mode. This configuration uses the
two working electrodes in the flow channel independently potentiostatically controlled. This can be
compared to fluorescence detection with the product of the upstream electrode being detected at the
downstream working electrode. When using amperometric cells such as the thin-layer cell (TLC) in the
series mode only a small percentage of the compounds passing through the downstream generator cell
will be electrochemically oxidised or reduced. The same is true for the second upstream amperometric
electrode, which will in turn convert only a fraction of the products generated by the first electrode.
Nevertheless, such an approach has been shown to be successful for the determination of a number of
benzodiazepines [20,21] and nitro aromatic compounds [22].
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The related parallel adjacent approach has been used by Evans [23] for the determination of
several organic peroxides. The configuration of this detector allows for the cascade of reversible
redox reactions in order to amplify the detector current. In this configuration, the working electrodes
are on opposite sides of a very thin channel, with one electrode at an oxidative potential and one
at a reducing potential. When the spacer is thick, then the two electrodes can act as independent
parallel dual electrodes, but with a thin spacer products of one electrode can diffuse to other and
vice versa. When the electrodes are sufficiently large, each analyte particle can pass through a number
of oxidation-reduction cycles, so that the conversion efficiency of the cell can be much larger.
2.4. Pulse Amperometric Detection
Pulsed integrated amperometry (PIA) uses a multistep potential-time waveform that rapidly
alternates between an amperometric detection mode with oxidative cleaning reductive reactivation
potentials. It provides significant enhancement of sensitivity for compounds generally considered
as non-electroactive for detection under constant applied potential and with poor optical properties
for spectrophotometric detection (carbohydrates, amines, thiols) and macromolecules of biological
importance (peptides, proteins). PIA is based on the capacity of Au to catalyse the oxidation of
organic compounds [24]. The unsaturated d-electron orbitals present in the Au can bind and stabilise
free-radical intermediates generated during electrochemical oxidation, promoting electron transfer
from the oxidised analyte to the Au surface [25] hence allowing for the quantification of the target
analyte. This approach can lead to the accumulation of oxidation products at the gold surface and
the eventually fouling and leading to the loss sensitivity. To overcome this, potential is step to a
positive potential for a short limited time to desorb the surface contaminants via the formation of Au
oxides [26]. The potential is then stepped to a third, negative value to reduce the Au oxides formed,
regenerating the original clean Au surface. Such multi-step waveforms are repeated continuously
through the duration of the analysis. For measurement of amino acids and amino sugars, a different
series of steps is used to maintain slightly higher potentials during detection such that the Au surface
is maintained in an oxide state [25]. For the determination of saccharides, liquid chromatography
with-PIA detection is reported to be two orders of magnitude more sensitive than LC with refractive
index detection [27].
2.5. Coulometric Detectors
A number of different coulometric detector designs have been developed, with the majority of
reported applications utilizing the commercially available Coulochem detector. A simplified cross
section of this is shown in Figure 3. These utilise flow-through porous carbon electrodes with high
surface areas reducing diffusion distances giving close to 100% conversion efficiency (coulometric).
These high conversion rates of the analyte passing through them as predicated by Faraday’s Law
can result in high sensitivity. However, the larger currents generated do not necessarily lead to
improvements in signal-to-noise ratios or to detection limits due to the concomitant increase in noise.
Nevertheless, these high coulometric efficiencies offer a number of other potential advantages when
two or more of these electrodes are used in the series after the liquid chromatographic column.
When two or more electrodes are arranged in series these can be applied in what is commonly
referred to as the screening mode. Compounds eluting from the analytical column entry the first
upstream electrode cell which is held at a potential high enough to oxidise or reduce, and hence
remove some of the possible interfering compounds. By careful selection of the potential of this
first screening electrode, the target analytes can pass through unaltered, and can be measured at the
downstream detector electrode, but now in the absence of a number of the potential interferences
originally present in the sample. A variation of this concept has led to the development of detectors
consisting of up to sixteen coulometric detectors in series, to form a coulometric array; the application
of which has been extensively reviewed [28–31]. A further alternative method is what has been termed
the generator/detector mode. Here the first upstream working electrode can be used as a generator,
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with the second working electrode, as the detector. The generator electrode can be used to form an
electrochemical active product, which can then be measured at the second downstream detector
electrode giving the advantage of it being much more easily oxidized or reduced than the parent
compound. Other possible interferences present in the sample extract will be irreversibly reduced or
oxidized by the downstream generator electrode, similar to the screening mode, and will not be seen
at the upstream detector. Due to the lower potentials now required at the detector a number of other
advantages are gained, such lower background currents and less potential interferences.
Separations 2016, 3, 28 5 of 29 
 
extensively reviewed [28–31]. A further alternative method is what has been termed the 
generator/detector mode. Here the fir t upstr am working elect ode can be us d s a generator, with 
the second working electrode, as t e detector. The generator electrode can be used to form an 
electrochemical active product, which can then be measured at the second downstream detector 
electrode giving the advantage of it being much more easily oxidized or reduced than the parent 
compound. Other possible interferences present in the sample extract will be irreversibly reduced or 
oxidized by the downstream generator electrode, similar to the screening mode, and will not be seen 
at the upstream detector. Due to the lower potentials now required at the detector a number of other 
advantages are gained, such lower background currents and less potential interferences. 
 
Figure 3. Cross section through a dual coulometric electrode showing the placement of working, 
counter and palladium-hydrogen reference electrodes, after Honeychurch [18]. 
3. Applications 
3.1. Cannabinoids 
A number of different chromatographic approaches have been employed for the determination 
of cannabis and its constituent cannabinoids and have been reviewed [32]. HPLC-UV procedures are 
widely used for the analyses of the cannabinoids utilising wavelengths between 215 and 280 nm. 
However, the sensitivity of the electrochemical detector has been shown to be over 400 times greater 
than that obtained by UV at 220 nm [33]. Around 70 different cannabinoid compounds are reported 
present in herbal cannabis [34], however, Δ9-Tetrahydrocannabinol (I) (THC) is the major 
psychoactive component and methods for its determination are consequently more commonly 
reported. Nyoni et al. [35] have developed a LC ED based method to assist in investigating the 
biochemical mechanism(s) of THC (I) in brain tissue. The method employed solvent extraction with 
methanol-hexane-ethyl acetate, followed by analysis using LC ED. Overall recoveries were reported 
to be greater than 80%. 
Bourquin and Brenneisen [36] utilised reverse phase LC ED for the determination of the major 
metabolite of THC, 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid (II) (THC–COOH) in urine. 
Separation was achieved using a mobile phase of methanol-5% aqueous acetic acid (76:24) at a flow-
rate of 1.5 mL/min. The detector was operated in the amperometric mode, at an applied potential of 
+1.2 V (vs. Ag/AgCl). A 10 mL aliquot of human urine was fortified with internal standard 
(cannabinol) and hydrolysed with KOH by heating to convert the excreted glucuronide conjugates 
to free, unconjugated THC–COOH (II). The sample pH was then adjusted to pH 5–6 and the internal 
standard and THC–COOH (II) isolated by solid phase extraction (SPE) [37]. Both THC–COOH (II) 
and the internal standard were reported to have the same recovery of 90% ± 5%. The limit of detection 
for THC–COOH (II) was 5 ng/mL of urine based on a signal-to-noise-ratio of 5:1. The standard 
calibration curve was obtained by using blank urine spiked with 25–300 ng/mL THC–COOH (II) and 
90 ng/mL internal standard. 
Figure 3. Cross section through a dual coulometric electrode showing the placement of working,
counter and palladium-hydrogen reference electrodes, after Honeychurch [18].
3. Applications
3.1. Cannabinoids
A number of iffere t chrom tograph c appro ches hav b en employed for the determination of
cannabis and its constituent cannabinoids and have been reviewed [32]. HPLC-UV procedures are
widely used for the analyses of the cannabinoids utilising wavelengths between 215 and 280 nm.
However, the sensitivity of the electrochemical detector has been shown to be over 400 times
greater than that obtained by UV at 220 nm [33]. Around 70 different cannabinoid compounds
are reported present in herbal cannabis [34], however, ∆9-Tetrahydrocannabinol (I) (THC) is the
major psychoactive component and methods for its determination are consequently more commonly
reported. Nyoni et al. [35] have developed a LC ED based method to assist in investigating the
biochemical m cha ism(s) of THC (I) in brain tissue. The method employed solvent extraction with
methanol-hexane-ethyl acetate, followed by analy is using LC ED. Overall recoveries were reported to
be greater than 80%.
Bourquin and Brenneisen [36] utilised reverse phase LC ED for the determination of the major
metabolite of THC, 11-nor-∆9-tetrahydrocannabinol-9-carboxylic acid (II) (THC–COOH) in urine.
Separation was achieved using a mobile phase of methanol-5% aqueous acetic acid (76:24) at a
flow-rate of 1.5 mL/min. The detector was operated in the amperometric mode, at an applied potential
of +1.2 V (vs. Ag/AgCl). A 10 mL aliquot of human urine was fortified with internal standard
(cannabinol) and hydrolysed with KOH by eating to convert the excreted glucuronide conjugates to
free, unconjugated THC–COOH (II). The sample pH wa then adju ted t pH 5–6 and the internal
standard and THC–COOH (II) isolated by solid phase extraction (SPE) [37]. Both THC–COOH (II) and
the internal standard were reported to have the same recovery of 90% ± 5%. The limit of detection for
THC–COOH (II) was 5 ng/mL of urine based on a signal-to-noise-ratio of 5:1. The standard calibration
curve was obtained by using blank urine spiked with 25–300 ng/mL THC–COOH (II) and 90 ng/mL
internal standard.
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Further investigations [38] into the simultaneous determination of THC and the further 
metabolites THC–COOH and 11-hydroxy-Δ9-tetrahydrocannabinol (III) (11-OH THC) in urine and 
plasma by LC ED have been reported. Biological fluids were first hydrolysed by heating in base and 
then acidified and extracted with a previously described automatic extractor [39] and determined by 
LC ED with amperometric determination at +1.1 V. Liquid chromatography was carried out with a 
reversed-phase silica C8 column and a mobile phase of acetonitrile/methanol/0.02 N H2SO4 (35:15:50) 
at a flow rate of 1.8 mL/min. A detection limit of under 0.5 ng/mL (S/N > 3) with a linear range of 10–
500 ng/mL was reported. Using this approach it was found possible to detect THC–COOH (II) in 
rabbit urine up to 216 h after administration. Investigations were also made on samples of human 
urine obtained from 23 men arrested on the suspicion of smoking marijuana and results showed good 
agreement with those obtained by GC/MS [40]. 
THC has also been determined in human urine using a novel brominated 9-carboxy-11–nor-Δ9-
tetrahydrocannabinol as an internal standard [41]. Amperometric determination was undertaken at 
+0.85 V (vs. Ag/AgCl) using gradient elution. Problems generally exist with the application of 
gradient elution when used in conjugation with LC ED. Electrochemical detector background current 
is a function of organic solvent composition and ionic strength. Consequently, the application of 
solvent gradient will result in a continually changing background current. However, the authors 
showed that this can be minimized by making the ionic strengths of the two components of the mobile 
phase identical. Using this approach the authors reported only a small shift in the baseline of around 
1 to 2 nA. After addition of internal standard samples of human urine were adjusted to be between 
pH 4.5 and pH 6.5 and isolated by SPE. No interferences were reported for 22 drugs and metabolites. 
A pooled relative standard deviation of 4.1% (n = 27) was obtained for the quality control samples 
and the method showed good agreement with results obtained by gas chromatography/mass 
spectrometry. 
Nakahara and Tanaka [42] have develop a chemotaxonomical based LC ED method for the 
discrimination of confiscated cannabis samples. Eleven different samples were investigated and on 
the basis of their liquid chromatographic cannabinoid profiles. They demonstrated the possibility of 
distinguishing cannabis products grown in three districts of Japan, Colombia, The Philippines and 
Nepal. The stability of cannabinoids in cannabis products was also examined at room temperature,  
4 °C and −20 °C. After 16 months, it was found that 90% of original THC (I) remained at −20 °C, 50% 
and 28% of original THC (I) had decomposed at room temperature and 4 °C, respectively. Almost all 
of the decomposed THC (I) had changed to cannabinol by air oxidation. 
Nakahara and Sekine [42] have used LC ED for the determination of free cannabinoids and 
cannabinoic acids obtained from marijuana cigarettes and in tar and ash obtained by using an 
automatic smoking machine. Separation was achieved using reverse phase chromatography with 
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for its anti-emetic and orexigenic effects in cancer patients receiving chemotherapy. Kokubun et al. 
Further investigations [38] into the simultaneous determination of THC and the further
metabolites THC–COOH and 11-hydroxy-∆9-tetrahydrocannabinol (III) (11-OH THC) in urine and
plasma by LC ED have been reported. Biological fluids were first hydrolysed by heating in base and
then acidified and extracted with a previously described automatic extractor [39] and determined by
LC ED with amperometric determination at +1.1 V. Liquid chromatography was carried out with a
reversed-phase silica C8 column and a mobile phase of acetonitrile/methanol/0.02 N H2SO4 (35:15:50)
at a flow rate of 1.8 mL/min. A detection limit of under 0.5 ng/mL (S/N > 3) with a linear range of
10–500 ng/mL was reported. Using this approach it was found possible to detect THC–COOH (II) in
rabbit urine up to 216 h after administration. Investigations were also made on samples of human
urine obtained from 23 men arrested on the suspicion of smoking marijuana and results showed good
agreement with those obtained by GC/MS [40].
THC has also been determined in human urine using a novel brominated 9-carboxy-11–nor-∆9-
tetrahydrocannabinol as an internal standard [41]. Amperometric determination was undertaken
at +0.85 V (vs. Ag/AgCl) using gradient elution. Problems generally exist with the application of
gradient elution when used in conjugation with LC ED. Electrochemical detector background current is
a function of organic solvent composition and ionic strength. Consequently, the application of solvent
gradient will result in a continually changing background current. However, the authors showed
that this can be minimized by making the ionic strengths of the two components of the mobile phase
identical. Using this approach the authors reported only a small shift in the baseline of around 1 to
2 nA. After addition of internal standard samples of human urine were adjusted to be between pH 4.5
and pH 6.5 and isolated by SPE. No interferences were reported for 22 drugs and metabolites. A pooled
relative standard deviation of 4.1% (n = 27) was obtained for the quality control samples and the
method showed good agreement with results obtained by gas chromatography/mass spectrometry.
Nakahara and Tanaka [42] have develop a chemotaxonomical based LC ED method for the
discrimination of confiscated cannabis samples. Eleven different samples were investigated and on
the basis of their liquid chromatographic cannabinoid profiles. They demonstrated the possibility of
distinguishing cannabis products grown in three districts of Japan, Colombia, The Philippines and
Nepal. The stability of cannabinoids in cannabis products was also examined at room temperature,
4 ◦C and −20 ◦C. After 16 months, it was found that 90% of original THC (I) remained at −20 ◦C, 50%
and 28% of original THC (I) had decomposed at room temperature and 4 ◦C, respectively. Almost all
of the decomposed THC (I) had changed to cannabinol by air oxidation.
Nakahara and Sekine [42] have used LC ED for the determination of free cannabinoids and
cannabinoic acids obtained from marijuana cigarettes and in tar and ash obtained by using an automatic
smoking machine. Separation was achieved using reverse phase chromatography with mobile phase
of 0.02 N H2SO4, methanol acetonitrile (6:7:16) at a flow rate of 1.1 mL/min. Amperometric detection
was undertaken using an applied potential of +1.2 V (vs. Ag/AgCl) and a liner range of 5 to
500 ng/injection was reported with detection limits of 0.5 to 0.9 ng/injection for free cannabinoids
and 1.2 to 2.5 ng/injection for cannabinoic acids (S/N > 4). THC (I) and several related cannabinoids:
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cannabidiol (IV), cannabinol (V), cannabichromene (VI) and their acid derivatives could be resolved
using the chromatographic conditions described.
In its pure synthetic form THC has been developed as the drug dronabinol, which has been used
for its anti-emetic and orexigenic effects in cancer patients receiving chemotherapy. Kokubun et al. [43]
have developed a LC ED amperometric method to investigate the pharmacokinetics of dronabinol in
cancer patients and its quantitation in blood. Reverse phase chromatography was undertaken using
and a mobile phase of 50 mM KH2PO4/CH3CN (9:16). Detection was undertaken using an applied
potential of +0.40 V. The calibration curve was linear in the range of 10 ng/mL to 100 ng/mL. The lower
limit of quantification was 0.5 ng/mL (S/N = 3). The relative within-runs and between-runs standard
deviations for the assay were less than 4.7%. Table 1 gives a summary of the LC ED approaches
reported for the determination of cannabinoid compounds.
Table 1. Liquid chromatography electrochemical determination of cannabinoids.
LC ED Technique ReferenceElectrode Linear Range Detection Limit Comments Ref.
Amperometric mode;
+1.2 V Ag/AgCl 25–300 ng/mL
5 ng/mL of urine
(S/N = 5) THC–COOH in urine [36,37]
Amperometric mode;
+1.2 V Ag/AgCl Up to 10 µg/mL 1.5 ng on column
∆9-tetrahydrocannablnol
levels in brain tissue
[35]
Amperometric mode;
+1.1 V Ag/AgCl 10–500 ng/mL 0.5 ng/mL (S/N > 3)
THC and metabolites;
THC–COOH) and 11-OH THC
in rabbit and human urine
[38]
Amperometric mode;
+0.85 V Ag/AgCl 0.012–0.20 µg/mL
THC–COOH is
0.012 µg/mL
(limit of quantification)
in human urine
Brominated 9-Carboxy-11-nor
∆9 tetrahydrocannabinol as
internal Standard
[41]
Amperometric mode;
+1.0 V Ag/AgCl 1–500 µg/mL –
Chemotaxonomical
discrimination of confiscated
cannabis. Studies made on
stablity of cannabinoids in
herbal cannabis. Mobile phase:
CH3CN/CH3OH/0.02 N
H2SO4. Benozic acid as
internal standard
[42]
Amperometric mode;
+0.40 V Ag/AgCl 10–100 ng/mL
Limit of
quantification:
0.5 ng/mL (S/N = 3)
Blood THC levels in patients
given the drug dronabinol [43]
Amperometric mode;
+1.2 V Ag/AgCl 5–500 ng/injection
0.5 to 0.9 ng/injection
for free cannabinoids
and 1.2 to
2.5 ng/injection for
cannabinoic acids
(S/N > 4).
Cannabinoic contents in
marijuana cigarettes and in tar
and ash
[33]
3.2. Ethanol
The determination of the degree of alcohol consumption is an important parameter commonly
studied in forensic investigations. In post-mortem investigations, the presence of ethanol can be
a result of either consumption prior to death, or due to fermentation as part of the decomposition
process. To be able to differentiate between the two possibilities, a common approach is to monitor
the biological metabolites for ethanol generated before death, such as ethyl glucuronide (VII) (EtG).
However, alkyl-glucuronides such as EtG only adsorb at low UV wavelengths, and hence have little
analytical utility. In light of this a method for the determination of EtG has been recently developed [44]
using reversed-phase liquid chromatography coupled with pulsed electrochemical detection (PED) [45].
EtG was quantified using methyl glucuronide as an internal standard, and was separated using a
mobile phase consisting of 1% acetic acid/acetonitrile (98/2, v/v). Post-column addition of NaOH
(600 mM) at 0.5 mL/min allowed for the detection of all glucuronides using PED at a gold working
electrode vs. Ag/AgCl. A limit of detection of 0.03 µg/mL for a 50 µL injection volume was reported
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with a coefficient of variation of 1.7% at the limit of quantitation. Sample clean-up and isolation
was achieved via SPE using an aminopropyl phase cartridge, gaining a recovery of approximately
50% ± 2%. Investigation of 29 post-mortem urine specimens were undertaken, and results were found
to agreed strongly with certified determinations.
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for heroin (IX). Limits of detection for extracted sample were 0.5 ng/mL morphine (VIII), 3.1 ng/mL
hydromorphone (XV), and 12.5 ng/mL heroin (IX). Average extraction recovery percentages were 70%
morphine (VIII), 57% hydromorphone (XV), 55% heroin (IX), and 78% nalorphine (XVI). Forty-five other
drugs were investigated as possible interferences. Out of theses only acetaminophen, aminopyrine,
cyanide, disopyramide, ketamine and nalorphine were found to give chromatographic peaks, but
were reported not to interfere. Material from six human post-mortem cases of suspected heroin related
death were examined and the concentrations of heroin (IX) and morphine (VIII) determined in both
blood and urine showed good agreement with those obtained by radioimmunoassay.
Zaromb et al. [53] have investigated the determination of airborne cocaine (XIV) and heroin
(IX) using high-throughput liquid adsorption pre-concentration. Air was sampled at a rate over the
range 550–700 L/min with a preferred ranged of 620–680 L/min. Detection limits of ca. 1:1013 (v/v)
of the drugs were achieved. LC ED was undertaken using a mobile phase of potassium phosphate
buffer (pH 7–7.4, 0.02 M)-acetonitrile (40:60, v/v) at a flow rate of 1.0 mL/min, at C18 stationary phase.
Amperometric detection was undertaken at a glassy carbon electrode at an applied potential of +1.0 V
(vs. Ag/AgCl).
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Dental cottons and cigarette filters are often used to filter dissolved or “cooked” drug solutions.
The solution is drawn into the syringe through the improvised filter prior to injection. Since drug
filtering with these cottons is prevalent and part of the drug paraphernalia used by intravenous drug
users (IDUs) in their injection ritual, they represent an ideal source for obtaining samples for analysis.
Huettl et al. have reported a high performance liquid chromatography electrochemical array detection
(HPLC-EA) [55] method for the determination of heroin (IX), morphine (VIII), codeine (X) and cocaine
(XIV) contained in these drug cottons. Two different extraction methods were investigated, using
either water or ethyl acetate to extract the drugs from the cotton filters. Following a 10 min incubated
at room temperature with the selected solvent, the samples were centrifuged and the supernatant
taken and either blown down to dryness in the case of ethyl acetate or in the case of water, diluted in
mobile phase and filtered before examination by HPLC-EA. Due to the heterogeneous nature of the
drug cotton samples standard addition was employed to verify the retention time of the target analytes
heroin (IX), morphine (VIII), codeine (X) and cocaine (XIV). Separation and analysis of the extracts
were carried out using a CoulArray gradient HPLC coupled to a twelve coulometric electrochemical
array detector arranged in series after the analytical column. The potentials of each of the electrodes in
the array was set at increasing potentials of (1) 300 mV; (2) 350 mV; (3) 400 mV; (4) 450 mV; (5) 500 mV;
(6) 550 mV; (7) 600 mV; (8) 650 mV; (9) 700 mV; (10) 750 mV; (11) 850 mV and (12) 950 mV. Sample
separation was accomplished using an end-capped cyano (100 mm × 4.6 mm, 5 µm, CPS-2 Hypersil)
column (Thermo Scientific, Waltham, MA, USA) with gradient elution. Initial conditions of 95% (A)
30 mM dibasic sodium phosphate, pH 2.95, 5% (B) 30 mM dibasic sodium phosphate, 30% ethanol,
pH 2.95 at a flow rate of 1 mL/min for 5 min. The concentration of component (B) was then ramped to
80% over a period of 30 min. Detection limits of the HPLC-EA system were reported as: 4 pg/µL for
morphine (VIII), 24 pg/µL for codeine (X), 444 pg/µL, heroin (IX) and 576 pg/µL for cocaine (XIV).
The authors reported that it would be possible by using a slightly modified method to determine
lysergic acid diethylamide (XXI) (LSD) and the THC metabolites: 11-hydroxy-∆9-tetrahydrocannabinol
(11-OH-∆9-THC) and 11-nor-∆9-tetrahydrocannabinol-9-carboxylic acid (11-nor-∆9-THC-9-COOH).
Investigations were also made into the possibility to associate a particular chromatographic profile
with different cuts of injectable drugs. Drug cottons were obtained from different areas of Denver, USA
to investigate this possibility using the output of channel 12 (950 mV) of the HPLC-EA. The possibility
of developing a database based on these results was reported.
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Elut C18 (1 mL) SPE cartridges. Average extraction efficiencies of morphine (VIII), morphine-3-
glucronitide and morphine-6-glucronitide were 95.4%, 96.1% and 96.8%, respectively. Separations 
were achieved using a Supelcosi LC-8DB reverse phase column (Sigma-Aldrich, St. Louis, MO, USA) 
with a mobile phase of 0.1 M KH2PO4 (pH 2.5)-acetonitrile-methanol (94:5:1 v/v/v), containing 4 mM 
pentasulphonic acid as the mobile phase. The coulometric detection system was reported to give a 
detection limit of 0.5 ng/mL for morphine twenty times lower than that obtainable by UV at 201 nm 
under the same LC conditions. The limit of quantitation of morphine by LC-DED was reported to be 
1 ng/mL, compared to 10 ng/mL by UV detection. However, UV detection proved to be superior for 
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4,5-epoxy-17-methylmorphinan-3,6-diol) and its glucuronides; morphine-3-glucuronide, morphine-
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with a mobile phase of 0.1 M KH2PO4 (pH 2.5)-acetonitrile-methanol (94:5:1 v/v/v), containing 4 mM
pentasulphonic acid as the mobile phase. The coulometric detection system was reported to give a
detection limit of 0.5 ng/mL for morphine twenty times lower than that obtainable by UV at 201 nm
under the same LC conditions. The limit of quantitation of morphine by LC-DED was reported to
be 1 ng/mL, compared to 10 ng/mL by UV detection. However, UV detection proved to be superior
for the detection of the glucuronide metabolites. The response for morphine by LC-DED was found
to linear over the range 1–30 ng/mL with morphine-3-glucronitide from 50 to 2000 ng/mL and
morphine-6-glucronitide 15–1000 ng/mL.
Rashid et al. [57] have developed an immuno-solid-phase extraction method followed by
reverse-phase LC ED for the determination of morphine in urine. The polyclonal antibody solid-phase
extraction columns were fabricated from aldehyde-activated silica modified with polyclonal antibodies
raised in sheep in response to an N-succinyl-normorphine-bovine serum albumin conjugate. Urine
was diluted ten times with phosphate-buffered saline, pH 7.4 (PBS), loaded onto these solid-phase
immunoextraction columns and washed with PBS and before then being eluted with 40% ethanol in
PBS, pH 4. The eluted fraction was then analysed by LC ED using a cyanopropyl analytical column
with a mobile phase of 25% acetonitrile in phosphate buffer–sodium lauryl sulphate at pH 2.4 with a
flow rate of 1 mL/min. Electrochemical detection of morphine was performed with a Coulochem ESA
model 5100A set at a potential of +0.45 V. Calibration curves were reported to be linear from 100 ng/mL
to 500 ng/mL in urine. The inter-assay relative standard deviation was 10% with a corresponding
recovery of 98%. Minimal binding with other opiate metabolites such as codeine (X), normorphine,
norcodeine, morphine-3-glucuronide and morphine-6-glucuronide was reported.
Xu et al. [58] have modified a glassy carbon electrode (GCE) with cobalt hexacyanoferrate for the
liquid chromatographic amperometric determination of morphine (VIII) in rat brain microdialysates.
The electrode was modified electrochemically by voltammetric cycling from 0.0 V to +1.0 V at 100 mV/s
in a solution containing 0.5 mM K3Fe(CN)6 and 1.0 mM CoCl2 in 0.5 M KCl. The electrochemical
properties of the cobalt hexacyanoferrate film modified GCE were investigated by cyclic voltammetry
using 0.1 M phosphate buffered saline (pH 4.5) as the supporting electrolyte. At the unmodified GCE
no voltammetric responses were recorded. At the cobalt hexacyanoferrate modified GCE a number
of voltammetric responses were recorded, concluded to arise from the redox behaviour of Fe2+/Fe3+
couple. However, in the presence of 2.0 × 10−4 M morphine (VIII) at the cobalt hexacyanoferrate
modified GCE a further large oxidation peak was observed. The voltammetric peak potential for this
response was reported to have move to a more negative potentials compared to the direct oxidation of
morphine at the unmodified bare GCE. This was concluded to result from the electrocatalytic behaviour
of the cobalt hexacyanoferrate. LC ED investigations also showed that the peak current magnitude
at the modified cobalt hexacyanoferrate GCE was larger than that recorded at the bare GCE, 66 nA
compared to 15 nA for a 2.5 × 10−5 M morphine (VIII) standard. Liquid chromatographic separation
was undertaken using a mobile phase of 10:90 (v/v) methanol-0.1 M phosphate-buffered saline (PBS,
pH 4.5) which contained 1.0× 10−4 M Na2EDTA at a flow rate of 1.0 mL/min with an injection volume
was 25 µL. The stationary phase was a HP Hypersil column (5 mm, 200 × 4.6 mm) (Thermo Scientific,
Waltham, MA, USA). Amperometric detection of morphine (VIII) was performed at a potential of
+0.60 V (vs. Ag/AgCl). A linear response for morphine was reported over the concentration range
1.0 × 10−6 M to 5.0 × 10−4 M (R2 > 0.990) with a corresponding detection limit of 5.0 × 10−7 M (S/N
of 3). The morphine (VIII) concentration in the brain dialysis samples collected from anesthetized
male (Sprague-Dawley) rats (250–300 g) sampled at different time intervals after morphine (VIII) was
administered intravenously (25 mg/kg). The relative recoveries of morphine (VIII) at the perfusion
rates of 12.0, 9.0, 6.0, 3.6, 3.0, 2.4, 1.5 mL/min were investigated and a perfusion rate of 3.6 mL/min was
considered optimum. Morphine (VIII) could be readily detected in brain dialysate and no interferences
were recorded at or around the retention time of morphine (VIII) (4.60 min).
A number of studies have utilised LC ED for the investigation of the pharmacokinetics of
morphine in dogs [59–61]. Most recently Aragon et al. [61] have investigated the pharmacokinetics of
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a human oral morphine formulations consisting of both immediate and extended release components
in adult Labrador Retrievers dogs. In their randomized design, 14 dogs were administered either 1 or
2 mg/kg morphine orally. Plasma samples were collected up to 24 h after drug administration and
extracted by SPE. Concentrations of morphine (VIII) were determined by reverse-phase LC ED with
gradient elution. The mobile phase consisted of 95% 0.01 M acetate buffer with 0.1% triethylamine
and 5% acetonitrile with the pH adjusted to 4.5 with glacial acetic acid. The mobile phase gradient
elution program consisted of 100% of this mobile phase mixture for 8 min, 85% mobile phase with
15% acetonitrile for 8–11 min and 100% mobile phase for 11–14 min. Separation was achieved with a
4.6 × 150 mm and 5 µm particle size column maintained at 40 ◦C. Dual electrode coulometric detection
was undertaken using a guard cell +750 mV; electrode 1 +300 mV; electrode 2 +450 mV, with electrode 2
used for quantification. The retention times for morphine and morpine-6-glucronide were 7.5 and
5.5 min with limits of quantification of 7.8 ng/mL and 4 ng/mL respectively. Table 2 summaries
reported LC ED application for the determination of alkaloids.
Fisher et al. [62] have compared the serum concentrations of morphine after administration of a
buccal tablet (25 mg) with those obtained after intramuscular injection (10 mg). Buccal morphine was
administered to eleven healthy volunteers and intramuscular morphine was given to five preoperative
surgical patients. Serum morphine concentrations were assayed by LC DED in samples taken up to
8 h after drug administration. Electrochemical detection was carried out using a 5100A Coulochem
detector fitted with a 5100 detector cell (ESA). The potential of electrode 1 was maintained at +0.25 V
and electrode 2 at +0.40 V. The lower limit of detection was reported to be 0.8 ng/mL morphine
base. Morphine (VIII) analysis was carried out using the extraction and chromatographic procedure
described by Todd et al. [63]. Mean maximum morphine concentrations were eight times lower
after buccal administration than after intramuscular injection and occurred at a mean of 4 h later.
Individual morphine concentration-time profiles showed marked inter individual variability after
administration of the buccal tablet, consistent with considerable variation in tablet persistence time on
the buccal mucosa.
Jordan and Hart [64] have investigated the determination of morphine (VIII) by liquid
chromatography with amperometric determination at a GCE. Using cyclic voltammetry they showed
that pH 11.0 was optimum for the electrochemical determination of morphine (VIII). Further
investigations showed that a mobile phase of 50 mM pH 11.0 phosphate buffer of containing 20% v/v
of acetonitrile was found optimum. Hydrodynamic voltammetric investigations over the range +0.15
to +1.10 V identified three distinct waves can be seen at +0.45 V, +0.8 V and a third at +1.0 V. Using an
applied potential of +0.45 V with hydromorphone (XXII) as an internal standard, a linear response was
observed from 1.2 × 10−12 to 4 × 10−10 M of morphine injected. At the applied potential of +0.45 V
(vs. Ag/AgCl) and for a signal-to-noise ratio of 3:1, the detection limit was found to be 1.24 × 10−13 M
of morphine injected.
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Table 2. Liquid chromatography electrochemical determination of alkaloids.
Analyte LC ED Technique Reference Electrode Linear Range Detection Limit Comments Ref.
Cocaine and heroin Amperometric mode;+1.0 V Ag/AgCl 25–300 ng/mL ca. 1:10
13 (v/v)
Airbourne concentrations of
cocaine and heroin [53]
Heroin, morphine and
hydromorphone
Amperometric mode;
+0.5 V Ag/AgCl
l0 to 500 ng/mL (morphine),
62 to 1000 ng/mL
(hydromorphone), and 250 to
2000 ng/mL (heroin)
For extracted sample was 0.5 ng/mL
(morphine), 3.1 ng/mL
(hydromorphone), and 12.5 ng/ mL
(heroin)
Post-mortem samples of whole
blood, urine, or vitreous humor [52]
Morphine, heroin,
codeine, thebaine,
narcotine, papaverine
and cocaine
Amperometric mode;
+1.2 V Ag/AgCl
Morphine base, 0.42–1.7 nM;
heroin hydrochloride,
1.6–6.5 nM; cocaine
hydrochloride, 3.1–12 nM.
0.3 ng for morphine, 1 ng for heroin,
and 2 ng for cocaine
Comparisum with LC UV
detection made [46]
Heroin, morphine,
codeine and cocaine
12 channel
electrochemical array PdH2 –
4 pg/mL for morphine, 24 pg/mL
for codeine, 444 pg/mL for heroin
and 576 pg/mL for cocaine
Analysis of drug cottens [55]
Morphine,
morphine-3-glucuronide
and
morphine-6-glucuronide
LC coulometric DED in
conjunction with UV
detection
PdH2 Morphine; 1–30 ng/mL Morphine; 0.5 ng/mL
Morphine and its glucuronides
extracted from human plasma
by SPE
[56]
Buprenorphine,
norbuprenorphine,
naloxone and
methadone
DED, screening −0.2 V
detector +0.6 V PdH2
buprenorphine and
norbuprenorphine,
3.0–1000.0 ng/mL for
methadone and
0.13–10.0 ng/mL for naloxone.
0.08 ng/mL for both buprenorphine
and norbuprenorphine, 0.9 ng/mL
for methadone and 0.04 ng/mL for
naloxone
Plasma smaples from heroin
addicts. Levosulpiride as an
internal standard
[54]
Morphine Amperometric mode;+0.60 V. 25 µL injection Ag/AgCl 1.0 × 10
−6 M to 5.0 × 10−4 M 5.0 × 10−7 M (S/N = 3). Rat brain dialysates. [58]
Morphine LC coulometric DED PdH2 – 0.8 ng/mL
Buccal and intramuscular
morphine adminstered to
humans
[62]
Morphine Amperometric mode;+0.45 V Ag/AgCl 1.2 × 10
−12 to 4 × 10−10 M 1.24 × 10−13 M hydromorphone as an internalstandard [64]
Morphine LC coulometric DED PdH2 –
Limits of quantification:
25 ng/L morphine
Guard cell +750 mV; cell 1
+300 mV; cell 2 +450 mV [60]
Morphine,
morpine-6-glucronide LC coulometric DED PdH2 –
Limit of quantification for morphine;
7 ng/mL and morpine-6-glucronide;
4 ng/mL
Guard cell +750 mV; cell 1
+300 mV; cell 2 +450 mV [59]
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Table 2. Cont.
Analyte LC ED Technique Reference Electrode Linear Range Detection Limit Comments Ref.
Morphine,
morpine-6-glucronide LC coulometric DED PdH2 –
limits of quantification: morphine;
7.8 ng/mL; morpine-6-glucronide
ng/mL
[61]
Morphine Amperometric mode;+0.75 V Ag/AgCl – –
Detection of morphine in toad
(Bufo marinus), rabbit and rat
skin, bovine adrenal,
cerebellum, cerebel cortex
[65]
Psilocybin
Amperometric mode;
+0.650 V using
5-hydroxyindole or
bufotenine as an
internal standard
Ag/AgCl 25–300 ng/mL limit of quantitation; 10 ng/mL
Pooled human blood bank
plasma and plasma obtained
from seven volunteers
(self-experimenting physicians)
[66]
Psilocin and
4-hydroxyindole-3-acetic
acid
LC coulometric DED PdH2 –
Limits of quantification of
0.8 ng/mL and 5.0 ng/mL for
psilocin and 4HIAA
Column-switching. Analysis of
human plasma [67]
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The hallucinogen psilocybin (XXIII) is one of the main psychoactive compounds found in Psilocybe
mushrooms. Psilocin (XXIV) is readily transformed to the phenolic compound psilocybin in the gut
as a result of dephosphorylation by alkaline phosphatase and is thus the substance responsible for
the reported psychedelic effects. Both psilocybin (XXIII) and psilocin (XXIV) are listed as Class A
(United Kingdom) or Schedule I (US) drugs under the United Nations 1971 Convention on Psychotropic
Substances. Interestingly, more recently, psilocin (XXIV) has been shown to have some promise
as a therapeutic agent in the treatment of conditions cluster headaches [3]. Lindenblatt et al. [66]
have used LC ED to determine levels of psilocin (XXIV) in plasma samples obtained from both
pooled human blood bank plasma and plasma obtained from seven volunteers (self-experimenting
physicians) taking oral doses of 0.2 mg psilocybin per kg body weight (maximum 15 mg per person) in
a placebo-controlled drug trial. Both liquid-liquid and automated SPE procedures were explored for the
isolation of psilocin (XXIV). The determination of psilocin (XXIV) obtained from liquid-liquid extracted
samples was undertaken using reverse phase chromatography with a 250 × 4.0 mm C18 column and
a mobile phase of 0.1 M sodium acetate, 0.1 M, citric acid, 0.03 mM Na2EDTA pH 4.1–acetonitrile
(83:17 v/v, 0.7 mL/min) with electrochemical detection at +0.650 V using 5-hydroxyindole (XXV)
as an internal standard. SPE extracts were determined using again, reverse phase chromatography
but, with a mobile phase of 150 mM pH 2.3 potassium dihydrogen phosphate buffer–acetonitrile
(94.5:5.5 v/v, 0.6 mL/min) with 160 mM Na2EDTA in the buffer–acetonitrile mixture. The potential of
the electrochemical detector was set at +0.675 V with quantification carry out using bufotenine (XXVI)
as an internal standard. The limit of quantitation for both methods was 10 ng/mL psilocin (XXIV).
However, on-line SPE showed better recoveries and selectivity and reportedly required less manual
effort and smaller plasma volumes of 400 µL, compared to 2 mL for liquid-liquid extraction.
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A liquid chromatographic procedure based on column-switching with electrochemical detection 
has been developed for the determination of psilocin (XXIV) and the metabolite 4-hydroxyindole-3-
acetic acid (XXVII) (4HIAA) in human plasma [67]. Plasma was extracted from blood samples by 
centrifugation. Ascorbic acid was then added to protect the phenol compounds against degradation 
and the samples freeze-dried. The resulting residues were then re-constituted in water and the 
psilocin and 4HIAA (XXVII) extracted by microdialysis (mean recovery: psilocin 15.1% ± 0.85%; 
4HIAA 11.0% ± 1.10%). 
A liquid chromatographic procedure based on column-switching with electrochemical
detection has been developed for the determination of psilocin (XXIV) and the metabolite
4-hydroxyindole-3-acetic acid (XXVII) (4HIAA) in human plasma [67]. Plasma was extracted from
blood samples by centrifugation. Ascorbic acid was then added to protect the phenol compounds
against degradation and the samples freeze-dried. The resulting residues were then re-constituted in
water and the psilocin and 4HIAA (XXVII) extracted by microdialysis (mean recovery: psilocin 15.1%
± 0.85%; 4HIAA 11.0% ± 1.10%).
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In order to avoid excess interfering plasma compounds such as ascorbic acid reaching the detector
cell a column-switching step was employed. This was achieved by connecting the outlet of the
injection valve was connected to a 5 cm Spherisorb RP-8 HPLC column allowing for pre-separation
of the injected sample dialysate. The outlet of this pr -column was conn ct d to the inlet of a second
six-port Rheodyne valve; the flow of the eluate could be directed either to the waste or to the
15 cm Spherisorb RP-8 HPLC analytical column. The mobile phase consisted of 47% (v/v) water
containing 0.3 M ammonium acetate buffered to pH 8.3 by addition of ammonia solution 25% and
53% (v/v) of ethanol with flow rate of 450 µL/min. Limits of qua tifica i n of 0.8 ng/mL and
5.0 ng/mL for psilocin (XXIV) and 4HIAA (XXVII) were reported respectively. The authors noted that
optimised liquid chromatography UV detection of psilocin (XXIV) resulted in a limit of quantitation of
approximately 10 ng/mL; allowing for measurement of only peak plasma concentrations. Similarly,
GC/MS was reported to how insufficient sensitivity with the additional disadvantage of requiring a
derivatising step.
3.4. Benzodiaz pines
The LC ED d termi ation of benzodiazepines has recently been review [68] and has been shown
to be a highly sensitive and selective approach. A number of further investigations have been reported
since this review in 2014. By using an in series-liquid chromatography dual electrode detection in the
redox mode, it is possible to electrochemically reduce aromatic nitro substituted benzodiazepines to
their corresponding hydroxylamine at the first “generator” electrode (Equation (1)).
Ar–NO2 + 4e− + 4H+→Ar–NHOH + H2O (1)
This species can then be readily measured at the subsequent downstream “detector” electrode via
oxidation to the nitroso (Equation (2)).
Ar–NHOH→Ar–N=O + 2e− + 2H+ (2)
This is attractive analytically; as this latter species can be measured at potentials close to that of 0 V,
away from many possible interfering compounds. This approach has been used for the determination
of nitro aromatic drug, nitrazepam (XXVIII) in bovine and human serum [20].
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Recently, Rohypnol (XXIX) (flunitrazepam) has been successfully determined in white
“cappuccino” style coffee by LC-DED by a novel dual reductive mode approach [20]. Studies were
performed to optimise the chromatographic conditions and were reported to be 50% acetonitrile,
50% 50 mM pH 2.0 phosphate buffer at a flow rate of 0.75 mL/min, employing a Hypersil C18,
5 mm, 250 mm × 4.6 mm column. Cyclic voltammetric studies were made to ascertain the redox
behaviour of Rohypnol (XXIX) at a glassy carbon electrode over the pH range 2–12. Hydrodynamic
voltammetry was used to optimise the applied potential at the generator and detector cells; these
were identified to be −2.4 V and +0.8 V for the redox mode and −2.4 V and −0.1 V for the dual
reductive mode respectively. A linear range of 0.5–100 mg/mL, with a detection limit of 20 ng/mL was
obtained for the dual reductive mode. Further studies were then performed to identify the optimum
conditions required for the LC-DED determination of Rohypnol (XXIX) in beverage samples. In order
to demonstrate the application of the LC-DED assay to forensic “drink spiking” cases a sample of
white cappuccino style coffee was fortified at a level of 9.6 µg/mL Rohypnol (XXIX). Figure 4 shows
the LC-DED chromatograms for extracts of (i) coffee spiked with 9.6 µg/mL and (ii) for unspiked
coffee. Clearly, when using the dual reductive mode the extracts showed well-defined signals for
Rohypnol (XXIX). However, when using the redox mode the region from a retention time of 11 min
onwards is totally obscured by a large off-scale unresolved peak, which completely masks the area
where Rohypnol (XXIX) elutes. The dual reductive mode was hence reported to give reliable data at
the concentrations investigated relevant to cases of drink spiking.
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3.5. Amphetamines 
Amphetamines can be difficult to determine electrochemically requiring high positive  
applied potentials for their determination. To overcome this problem, a derivatization using  
2,5-dihydroxybenzaldehyde (2,5-DBA) has been described by Alfredo Santagati et al. [69]. It was 
shown that 2,5-DBA could rapidly aminated the primary amines of amphetamine (XXX),  
4-hydroxynorephedrine (XXXI) and phenylethylamine (XXXII) (PHE), using borohydride exchange 
resin as a chemoselective reducing agent giving electroactive secondary amines. LC ED analysis was 
performed using reversed phase isocratic elution on a column 5 µm Hypersil ODS RP-18, 15 cm, with 
a mobile phase of methanol-NaH2PO4 buffer (50 mM, pH 5.5) (30:70 v/v) containing triethylamine 
(0.5% v/v). The electrochemical detection of the derivatised compounds was investigated by 
hydrodynamic voltammetry at a porous graphite electrode and under the chromatographic 
conditions employed the optimum potential was reported to be +0.6 V. The linearity of response was 
examined for each derivatised compound and was analysed using solutions in the range 10 to 40 
nM/mL. The correlation coefficients of the linear regression of the standard curves were greater than 
Figure 4. Representative chromatograms of “cappuccino” style white coffee samples obtained by
LC-DED in the redox mode for (i) fortified at 9.6 µg/mL (ii) LC-DED dual reductive mode, fortified at
9.6 µg/mL and (iii) unadulterated. R = Rohypnol (XXIX).
3.5. Amphetamines
Amphetamines can be difficult to determine electrochemically requiring high positive
applied potentials for their determination. To overcome this problem, a derivatization using
2,5-dihydroxybenzaldehyde (2,5-DBA) has been described by Alfredo Santagati et al. [69]. It was
shown that 2,5-DBA could rapidly aminated the primary amines of amphetamine (XXX),
4-hydroxynorephedrine (XXXI) and phenylethylamine (XXXII) (PHE), using borohydride exchange
resin as a chemoselective reducing agent giving electroactive secondary amines. LC ED analysis was
performed using reversed phase isocratic elution on a column 5 µm Hypersil ODS RP-18, 15 cm, with a
mobile phase of ethanol-NaH2PO4 buffer (50 mM, pH 5.5) (30:70 v/v) containing t iethylamine (0.5%
v/v). The electrochemical detection of th derivatis d comp unds was investiga ed by hydrodynamic
voltammetry at a porous graphite electrode and under the chromatographic conditions employed
the optimum potential was reported to be +0.6 V. The linearity of response was examined for each
derivatised compound and was analysed using solutions in the range 10 to 40 nM/mL. The correlation
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coefficients of the linear regression of the standard curves were greater than 0.99. A detection limit
based on a signal/noise ratio of 3:1 (S/N = 3) was less than 50 ng/mL for each compound and the
limits of quantitation were comprised in the range 0.3–0.6 µg/mL.
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undertaken using a potential of +920 mV. THC and THC–COOH were separated isocratically using a
LiChroCart, Superspher 60 RP select B column, 5 µm, 250 mm × 4 mm. The mobile phase consisted of
5.6 mM tetrabutylammonium hydrogen sulphate, pH 2.3–acetonitrile–tetrahydrofuran (44:46:10) with
0.160 mM Na EDTA. The flow-rate in this case was reported as 0.850 mL/min with electrochemical
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acetate–100 mM potassium chloride buffer, 30%:70% v/v using a flow rate of either 0.8 mL/min or
1.0 mL/min. Four different thin-layer flow cells investigated each employing a screen-printed sensor
for the amperometric detection of the two drugs at an applied potential of +1.4 V. The effect of flow rate
was investigated and improvements in sensitive were found at 0.8 mL/min compared to 1.0 mL/min.
Detection limits of 14.66 and 9.35 µg/mL for mephedrone (XXXIV) and 4-methylethcathinone (XXXV)
were reported. Analysis of the synthetic cathinones in a selection of purchased NRG-2 legal high
samples was undertaken. In samples containing caffeine UV and amperometric determination were
found to be comparable in terms of their ability to quantify the levels of caffeine present. Samples
containing only mephedrone (XXXIV) and 4-methylethcathinone (XXXV) showed a significant over
estimation of the quantities of the synthetic cathinones present in comparison to the HPLC-UV
detection. The authors concluded that this may be due to adsorption of the drugs on the electrode
surface and a new screen-printed sensor was employed for each sample analysis to overcome this.
The developed liquid chromatographic electrochemical method was found to be less sensitive than the
liquid chromatography with UV detection.
1 
 
 
3.7. Tryptamines, Phenethylamines and Piperazines
To restrict the sale of legal highs in April 2007 Japan introduced the Pharmaceutical Affairs
Law where substances such as tryptamines, phenethylamines and piperazines became under control
as ‘designated substances’ (Shitei-Yakubutsu). The relative large number of compounds required
a technique which was capable of separating, identifying and quantifying such compounds in
complex samples. To achieve this Min et al. [72] developed a liquid chromatographic multichannel
electrochemical detection (MECD) method for the simultaneous determination of 31 different
tryptamines, phenethylamines and piperazines. The compounds were separated by reverse phase
chromatography using a gradient elution. A coulometric electrode array detector (Model 5600A
CoulArray, ESA Inc., (Thermo Scientific, Waltham, MA, USA) equipped with 16 channel cell electrodes
(model 6210, porous graphite working electrode) was used for the detection. The optimum applied
potential for each substance was determined based by hydrodynamic voltammetry. The mobile phases
A and B consisted of 31.4 mM potassium phosphate buffer–methanol–acetonitrile (95:4:1; pH 6.7) and
60 mM potassium phosphate buffer–methanol–acetonitrile (50:40:10; pH 6.7), respectively. Separation
was performed using a reversed-phase ODS column (TSK-gel ODS-100V, 250 × 4.6 mm, 3 µm) with
gradient elution of 25% B (0–20 min), 10% B (20–60 min) and 10%–70% B (60–240 min) at the flow rate of
1.0 mL/min. The applied potentials of the 16 channel electrodes were set at 0, 90, 180, 270, 360, 450, 540,
630, 720, 810, 900, 990, 1080, 1170, 1260 and 1350 mV. Detection limits (S/N = 3) ranged from 17.1 pg
N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine (XXXVI) (5-MeO-MIPT) to 117 ng
2,3-dihydro-1H-inden-2-amine (XXXVII) (indan-2-amine). The developed method was evaluated by
the analysis of real samples. Solid samples (1 mg) were dissolved in 1.0 mL of a 50% methanol with
the aid of sonication and then centrifuged. The separated supernatant was filtered and the solutions
diluted 100 times with the initial mobile-phase starting solution and injected into the HPLC-MECD.
The target analytes were identified by their retention times and the hydrodynamic voltammograms of
authentic standards. Table 3 presents a summary of the applications discussed in this section.
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Table 3. Liquid chromatography electrochemical determination of synthetic drugs.
Analyte LC ED Technique Reference Electrode Linear Range Detection Limit Comments Ref.
Rohypnol
(flunitrazepam)
Dual amperometric
reductive-reductive mode;
electrode 1; −2.4 V and
electrode 2; −0.2 V
Stainless steel (generator cell);
Ag/AgCl (detector cell) 0.5–100 mg/mL 20 ng/mL Bovine and human serum [20]
Amphetamine and
4-hydroxynorephedrine
Porous graphite electrode;
+0.6 V. PdH2 10–40 nM/mL
50 ng/mL for each
compound
Derivatisation with
2,5-dihydroxybenzaldehyde [69]
Mephedrone and
4-methylethcathinone
Screen-printed carbon
electrode; +1.4 V Screen-printed Ag/AgCl
Mephedrone;
14.66 µg/mL;
4-methylethcathinone
9.35 µg/mL.
Samples of the ‘legal high’
NRG-2 analysed. [71]
Tryptamines,
Phenethylamines and
Piperazines
Multichannel
electrochemical detection PdH2
Ranged from 17.1 pg
to 117 ng
indan-2-amine
31 different drugs
determined [72]
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4. Comparisons with Other Liquid Chromatographic Detection Systems 
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trained staff. As a technique, LC/MS can suffer from issues with selectivity resulting from “isobaric” 
interferences, unpredictable ion yield attenuations from “ion suppression effects” [73]. Some of these 
issues can be overcome by the use of deuterated standards; however, these can be expensive. Table 4 
gives a comparison between the detection limits reported for both LC/MS and LC ED for several 
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notably better by LC ED; however, as a general approach LC/MS can be seen to be better across the 
range of analytes investigated. Liquid chromatography with UV detection (LC-UV) is both simple 
and reliable, but lacks the low detection limits that can be gained by both LC ED and LC/MS (Table 
4). Advantages can be gained using variants such as diode array detection (DAD) where spectra can 
be obtained for each eluting peak and can hence aid in peak identification and questions of peak 
purity. LC ED offers comparable, or in some cases better detection limits and is considerably less 
expensive than LC/MS. However, it can be affected by fouling of the electrodes leading to loss of 
sensitivity. The presence of oxygen and metal ions in the mobile phase can be an issue as well, but 
can be overcome by degassing and the addition of a chelating agent, approaches that are both 
commonly employed. 
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THC 0.5 [38] 1.0 [74] 746 [75] 
methadone 0.9 [54] 0.1 [76]   
buprenorphine 0.08 [54] 5.0 [76] 20 [77] 
norbuprenorphine 0.08 [54] 1.0 [76]   
morphine 0.5 [47] 0.5 [76] 10 [47] 
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issues can be overco e by the use of deuterated standards; however, these can be expensive. Table 4
gives a comparison between the detection limits reported for both LC/MS and LC ED for several drugs
of abuse. For a number of compounds detection limits are comparable and in some instance notably
better by LC ED; however, as a general approach LC/MS can be seen to be better across the range of
analytes investigated. Liquid chromatography with UV detection (LC-UV) is both simple and reliable,
but lacks the low detection limits that can be gained by both LC ED and LC/MS (Table 4). Advantages
can be gained using variants such as diode array detection (DAD) where spectra can be obtained for
each eluting peak and can hence aid in peak identification and questions of peak purity. LC ED offers
comparable, or in some cases better detection limits and is considerably less expensive than LC/MS.
However, it can be affected by fouling of the electrodes leading to loss of sensitivity. The presence of
oxygen and metal ions in the mobile phase can be an issue as well, but can be overcome by degassing
and the addition of a chelating agent, approaches that are both commonly employed.
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Table 4. Comparisons with Liquid Chromatography Mass Spectrometry.
Analyte LC ED DetectionLimit, ng/mL Ref.
LC/MS Detection
Limit, ng/mL Ref.
LC/UV Detection
Limit, ng/mL Ref.
THC 0.5 [38] 1.0 [74] 746 [75]
methadone 0.9 [54] 0.1 [76]
buprenorphine 0.08 [54] 5.0 [76] 20 [77]
norbuprenorphine 0.08 [54] 1.0 [76]
morphine 0.5 [47] 0.5 [76] 10 [47]
codeine 24 [55] 1.0 [76] 6.0 [78]
amphetamine <50 [69] 0.25 [76] 100 [79]
mephedrone 14,660 [71] 5.0 [80] 803 [81]
4-Methylethcathinone 9350 [71] 5.0 [80] 2410 [71]
psilocybin 0.8 [67] 2.0 [82] 50 [83]
Rohypnol 20 [84] 0.2 [82] 30 [85]
nitrazepam 100 [20] 1.25 [86]
5. Conclusions
The combination of liquid chromatography with electrochemical has been shown to a powerful
technique for the determination of drugs of abuse capable of determining trace concentration in
complex sample matrixes. The detection of morphine has seen the most interest presumably due
to the low applied potential required for its oxidation and it demand for its determination in both
pharmacology and forensic applications. Applications for new classes of illegal drugs are being
developed. However, the methods developed for the determination of the more established drugs
of abuse are generally depleted, preassembly, due to the introduction of competing techniques
such as LC/MS. The majority of methods have been based on reverse phase chromatography.
However, it is believed that more work will be reported on the application of techniques such as
hydrophilic interaction chromatography (HILIC) [87]. Similarly, the combination of electrochemistry
with mass spectrometry and LC/MS [88] will be become an increasingly important area for drug
metabolism studies.
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Abbreviations
The following abbreviations are used in this manuscript:
2,5-DBA 2,5-dihydroxybenzaldehyde
4HIAA 4-hydroxyindole-3-acetic acid
5-MeO-MIPT N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine
Ag/AgCl Silver/silver chloride
BAS Bioanalytical Systems, Inc.
EtG Ethyl glucuronide
GCE Glassy carbon electrode
GC/MS Gas chromatography mass spectrometry
HILIC Hydrophilic interaction chromatography
HMEA N-ethyl-4-hydroxy-3-methoxy-amphetamine
HPLC EA High performance liquid chromatography electrochemical array detection
HPLC-UV High performance liquid chromatography-ultra violet detection
IDU Intravenous drug user
LC-DED Liquid chromatography dual electrode detection
LC ED Liquid chromatography electrochemical detection
LC/MS Liquid chromatography mass spectrometry
LC-UV Liquid chromatography ultraviolet detection
LSD Lysergic acid diethylamide
MDE Methylenedioxyethylamphetamine
MECD Multichannel electrochemical detection
Na2EDTA Disodium ethylenediaminetetraacetic acid
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NRG-2 4-Methylethcathinone legal high marketed alone or in mixtures with other
substituted cathinones
PBS Phosphate buffered saline
PdH2 Palladium-hydrogen reference electrode
PED Pulsed electrochemical detection
PIA Pulsed integrated amperometry
PHE Phenylethylamine
S/N Signal-to-noise ratio
SPE Solid-phase extraction
THC Tetrahydrocannabinol
THC–COOH 11-nor-∆9-tetrahydrocannabinol-9-carboxylic acid
TLC Thin-layer cell
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